NOT-DC-21-002: Notice of NIDCD Withdrawal from Participation in PA-20-184, "Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)

Notice of NIDCD Withdrawal from Participation in PA-20-184, "Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)

Notice Number:

NOT-DC-21-002

Key Dates

Release Date:

May 10, 2021

Related Announcements

PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)

PAR-21-063 - NIDCD Low Risk Clinical Trials (R01 Clinical Trial Required)

PAR-21-064 - NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)

Issued by

National Institute on Deafness and Other Communication Disorders (NIDCD)

Purpose

Effective for the June 5, 2021 receipt date and beyond, the National Institute on Deafness and Other Communication Disorders (NIDCD) is no longer participating in PA-20-184 "Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required).

Principal Investigators interested in applying for a NIDCD-supported Clinical Trial should consider the following funding opportunity announcements (FOAs):

PAR-21-063- NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
Submit low risk clinical trials, including low risk Basic Experimental Studies with Humans (BESH)
PAR-21-064- NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 Clinical Trial Required)
Submit high risk clinical trials

Inquiries

Please direct all inquiries to:

Trinh T. Ly, M.D.
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-435-4085
Email: [email protected]